ARTICLE | Company News
Geron, Infigen gene/cell therapy news
February 2, 2004 8:00 AM UTC
GERN said the U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences finalized its January ruling that claims of Infigen's patent application for animal cloning technology are un...